Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An Overview of Novel Adjuvants Designed for Improving Vaccine Efficacy
Srinivasa Reddy Bonam, Charalambos D. Partidos, Sampath Kumar M. Halmuthur, et al.
Trends in Pharmacological Sciences (2017) Vol. 38, Iss. 9, pp. 771-793
Closed Access | Times Cited: 221

Showing 1-25 of 221 citing articles:

Combination Cancer Therapy with Immune Checkpoint Blockade: Mechanisms and Strategies
Shetal Patel, Andy J. Minn
Immunity (2018) Vol. 48, Iss. 3, pp. 417-433
Open Access | Times Cited: 493
Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines
Thai Thanh Hoang Thi, Estelle J. A. Suys, Jung Seok Lee, et al.
Vaccines (2021) Vol. 9, Iss. 4, pp. 359-359
Open Access | Times Cited: 366
Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want
Harm HogenEsch, Derek T. O’Hagan, Christopher B. Fox
npj Vaccines (2018) Vol. 3, Iss. 1
Open Access | Times Cited: 336
Next-generation influenza vaccines: opportunities and challenges
Chih‐Jen Wei, Michelle C. Crank, John W. Shiver, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 4, pp. 239-252
Open Access | Times Cited: 272
Liposomes used as a vaccine adjuvant-delivery system: From basics to clinical immunization
Ning Wang, Minnan Chen, Ting Wang
Journal of Controlled Release (2019) Vol. 303, pp. 130-150
Open Access | Times Cited: 249
Designing spatial and temporal control of vaccine responses
Gillie A. Roth, Vittoria C. T. M. Picece, Ben S. Ou, et al.
Nature Reviews Materials (2021) Vol. 7, Iss. 3, pp. 174-195
Open Access | Times Cited: 225
Polysaccharides as vaccine adjuvants
Beini Sun, Shuang Yu, Dongying Zhao, et al.
Vaccine (2018) Vol. 36, Iss. 35, pp. 5226-5234
Closed Access | Times Cited: 204
Adjuvants Enhancing Cross-Presentation by Dendritic Cells: The Key to More Effective Vaccines?
Nataschja I. Ho, Lisa G. M. Huis in ’t Veld, Tonke K. Raaijmakers, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 188
Vaccine Therapies for Cancer: Then and Now
Michael A. Morse, William R. Gwin, Duane A. Mitchell
Targeted Oncology (2021) Vol. 16, Iss. 2, pp. 121-152
Open Access | Times Cited: 171
COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies
Renuka Raman, Krishna Patel, Kishu Ranjan
Biomolecules (2021) Vol. 11, Iss. 7, pp. 993-993
Open Access | Times Cited: 167
Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach
Abdus Samad, Foysal Ahammad, Zulkar Nain, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 40, Iss. 1, pp. 14-30
Open Access | Times Cited: 161
Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance
Linda Del Bino, Kitt Emilie Østerlid, Dung‐Yeh Wu, et al.
Chemical Reviews (2022) Vol. 122, Iss. 20, pp. 15672-15716
Open Access | Times Cited: 111
Connecting Calcium-Based Nanomaterials and Cancer: From Diagnosis to Therapy
Shuang Bai, Yulu Lan, Shiying Fu, et al.
Nano-Micro Letters (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 101
New-age vaccine adjuvants, their development, and future perspective
Shailendra Kumar Verma, Pooja Mahajan, Nikhlesh K. Singh, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 93
Vaccine-like nanomedicine for cancer immunotherapy
Yunfei Yi, Mian Yu, Wen Li, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 760-778
Closed Access | Times Cited: 87
Recent Advances in the Lipid Nanoparticle-Mediated Delivery of mRNA Vaccines
K. Swetha, Niranjan G. Kotla, Lakshmi Tunki, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 658-658
Open Access | Times Cited: 63
Peptide-based vaccine for cancer therapies
Luigi Buonaguro, Maria Tagliamonte
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 43
In silico design of a novel multi-epitope vaccine against HCV infection through immunoinformatics approaches
Sajjad Ahmad, Fatemeh Mobini Demneh, Bushra Rehman, et al.
International Journal of Biological Macromolecules (2024) Vol. 267, pp. 131517-131517
Closed Access | Times Cited: 27
Boosting CAR-T cell therapy through vaccine synergy
Yan-Ruide Li, Zibai Lyu, Xinyuan Shen, et al.
Trends in Pharmacological Sciences (2025)
Open Access | Times Cited: 2
Immunoinformatics Approach for Epitope-Based Peptide Vaccine Design and Active Site Prediction against Polyprotein of Emerging Oropouche Virus
Utpal Kumar Adhikari, Mourad Tayebi, Mizanur Rahman
Journal of Immunology Research (2018) Vol. 2018, pp. 1-22
Open Access | Times Cited: 151
Natural and Synthetic Saponins as Vaccine Adjuvants
Pengfei Wang
Vaccines (2021) Vol. 9, Iss. 3, pp. 222-222
Open Access | Times Cited: 92
Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses
Tania Das Gupta, Shishir Kumar Gupta
International Immunopharmacology (2020) Vol. 86, pp. 106717-106717
Open Access | Times Cited: 86
Persistent Luminescence Immune Hydrogel for Photodynamic‐Immunotherapy of Tumors In Vivo
Gang Shu, Wang Zhu, Yingzong Jiang, et al.
Advanced Functional Materials (2021) Vol. 31, Iss. 36
Closed Access | Times Cited: 57
Protein-Based Adjuvants for Vaccines as Immunomodulators of the Innate and Adaptive Immune Response: Current Knowledge, Challenges, and Future Opportunities
Diego A. Díaz-Dinamarca, Michelle L. Salazar, Byron N. Castillo, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1671-1671
Open Access | Times Cited: 40
Novel adjuvants in allergen-specific immunotherapy: where do we stand?
Yen‐Ju Lin, Jennifer Zimmermann, Stefan Schülke
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top